{
    "paper_id": "PMC5890540",
    "metadata": {
        "title": "Addressing the selectivity and toxicity of antiviral nucleosides",
        "authors": [
            {
                "first": "Joy",
                "middle": [
                    "Y"
                ],
                "last": "Feng",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "As most nucleoside/tides analogs need to be transformed into 5\u2019-TP to exert on-target and off-target effects, their TP forms are necessary for elucidating these mechanisms (Table 1). The typical initial enzymatic assay for polymerases is a radioactivity-based polymerization assay, in which the inhibition by nucleotides is measured as an IC50 value. The inhibition IC50 assays can be easily adapted to a 96-well filter binding assay, and multiple compounds can be accessed simultaneously. However, based on inhibition studies alone, one cannot establish whether the nucleotide was actually incorporated. Therefore, a single nucleotide incorporation (SNI) assay can be particularly useful to determine if a NTP analog actually served as a substrate for the polymerases. Under a high concentration of NTP analogs (e.g. 500 \u00b5M ribose nucleotide TP (rNTP) or 50\u2013100 \u00b5M 2\u2032-deoxyribose nucleotide TP (dNTP)), the relative rate of incorporation of an analog can be compared to that of its natural NTP counterpart. For further mechanistic insight, a pre-steady state kinetic analysis of the NTP incorporation offers detailed kinetic parameters such as pre-steady state polymerization rate constant kpol and NTP dissociation constant Kd. In these studies, incorporation rates are studied using multiple time points and nucleotide concentrations, often using quench-flow techniques, making these studies reagent- and time-consuming. Finally, the mechanism of a nucleotide analog-derived enzyme inhibition can be revealed by an elongation assay, in which a stable elongation complex is formed, and the incorporation of the next few natural NTPs is measured. Normally, an NTP analog can be characterized into one of the three groups: chain-terminators, delayed chain-terminators, or stably incorporated analogs. Stably incorporated NTP analogs are difficult to study for toxicity as they could lead to little or no quantitative changes in DNA, RNA, or protein expression.36",
            "cite_spans": [
                {
                    "start": 1960,
                    "end": 1962,
                    "mention": "36",
                    "ref_id": "BIBREF29"
                }
            ],
            "section": "Biochemical evaluations",
            "ref_spans": [
                {
                    "start": 173,
                    "end": 180,
                    "mention": "Table 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "The quality of the above-mentioned biochemical assays relies heavily on the availability of high quality TP active forms, which can be time- and resource-consuming to synthesize, and the TP salts are subject to degradation overtime. At times, certain inorganic contaminants could lead to apparent inhibition of polymerases.",
            "cite_spans": [],
            "section": "Biochemical evaluations",
            "ref_spans": []
        },
        {
            "text": "Due to their mechanism of action, nucleoside analogs are generally evaluated for 5\u20138 days in both replicating laboratory-adapted cell lines and non-replicating primary cells.18 A standard readout is the effect of compound on the ATP level within the cells. We found that among 20+ laboratory-adapted cells we tested, prostate cancer-derived PC-3 cells and T-cell leukemia-derived MT4 cells are generally the most sensitive to toxins, and are significantly more sensitive than HepG2 cells, a widely used cell line for in vitro toxicity studies. In addition, we found that laboratory-adapted cells are as useful for detecting potential toxicity liabilities as primary cells.",
            "cite_spans": [
                {
                    "start": 174,
                    "end": 176,
                    "mention": "18",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "Toxicity is cell line-dependent ::: Cellular evaluations",
            "ref_spans": []
        },
        {
            "text": "In certain cases, testing in a specific cell assay is warranted. For example, a number of the first-generation HIV nucleoside analogs showed myelosuppressive effects. As a result, the FDA recommended evaluating this toxicity on the growth of human bone marrow progenitor cells in colony formation assays.37",
            "cite_spans": [
                {
                    "start": 304,
                    "end": 306,
                    "mention": "37",
                    "ref_id": "BIBREF30"
                }
            ],
            "section": "Toxicity is cell line-dependent ::: Cellular evaluations",
            "ref_spans": []
        },
        {
            "text": "A nucleoside/tide analog\u2019s cytotoxicity is often directly related to its cellular level of the active TP metabolite. BMS-986094 and IDX184 are both 2\u2032CMe guanosine nucleotide prodrugs, but the former formed >37-fold higher TP, and this correlated with its significantly higher toxicity.18 Some nucleoside analogs are poorly phosphorylated in cells, such as balapiravir. Even though it is a specific inhibitor of POLRMT, balapiravir showed little or no toxicity in a large panel of cell lines and primary cells tested, but development of this compound was stopped at Phase II due to toxicity.",
            "cite_spans": [
                {
                    "start": 286,
                    "end": 288,
                    "mention": "18",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "The importance of measuring cellular TP levels ::: Cellular evaluations",
            "ref_spans": []
        },
        {
            "text": "As shown in Table 1, we employed three mitochondria-focused cell-based assays to evaluate potential mitochondrial toxicity. The mitochondrial DNA content assay has been widely used to study 2\u2032-deoxy nucleoside analogs, but it does not assess the effect of ribose nucleoside/tide analogs on mitochrondrial RNA synthesis.20,29 ddC serves as a good positive control and HepG2 cells seem to be an ideal cell line for this assay.",
            "cite_spans": [
                {
                    "start": 319,
                    "end": 321,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 322,
                    "end": 324,
                    "mention": "29",
                    "ref_id": "BIBREF21"
                }
            ],
            "section": "Evaluation of mitochondrial toxicity ::: Cellular evaluations",
            "ref_spans": [
                {
                    "start": 12,
                    "end": 19,
                    "mention": "Table 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "The mitochondrial protein synthesis assay has been useful to evaluate ribonucleoside/tide analogs. In this assay, the levels of two proteins are measured simultaneously: the mitochondrial DNA-encoded protein cytochrome c oxidase 1 (COX-1) and a nuclear DNA-encoded protein succinate dehydrogenase A (SDH-A).32 For data analysis, we found that comparing the individual levels of the COX-1 and SDH-A proteins to the untreated DMSO control yielded more reproducible data than using the ratio of COX-1:SDH-A. Chloramphenicol, a specific inhibitor of mitochondrial protein synthesis, is used as the positive control.",
            "cite_spans": [
                {
                    "start": 307,
                    "end": 309,
                    "mention": "32",
                    "ref_id": "BIBREF25"
                }
            ],
            "section": "Evaluation of mitochondrial toxicity ::: Cellular evaluations",
            "ref_spans": []
        },
        {
            "text": "Since the 1950s, mitochondrial respiration has been regarded as the \u201cgold standard\u201d for the measurement of mitochondrial function.38 It has been used extensively to study mitochondrial toxins that directly impair the electron transport chain but has not been used to study the nucleoside/tide analogs until recently.39\u201342 This assay provides a sensitive functional readout and does not require knowledge of the mechanism of action.20 A complete loss of mitochondrial respiration capacity can be detected before any change in the cellular ATP level, and this phenomenon has been observed for inhibitors with diverse molecular targets including ddC (inhibitor of mitochondrial DNA synthesis), 4\u2032-azido cytidine (inhibitor of mitochondrial RNA synthesis), and chloramphenicol (inhibitor of mitochondrial protein synthesis). For compounds that show both mitochondrial and general toxicity (such as BMS-986094), this method makes it possible to identify whether mitochondria toxicity occurs at a lower drug concentration.20 For both mitochondrial protein and respiration assays, we found that PC-3 cells offer higher sensitivity and reproducibility than HepG2 cells.20",
            "cite_spans": [
                {
                    "start": 130,
                    "end": 132,
                    "mention": "38",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 316,
                    "end": 318,
                    "mention": "39",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 318,
                    "end": 318,
                    "mention": "",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 318,
                    "end": 318,
                    "mention": "",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 319,
                    "end": 321,
                    "mention": "42",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 431,
                    "end": 433,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 1016,
                    "end": 1018,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 1161,
                    "end": 1163,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "Evaluation of mitochondrial toxicity ::: Cellular evaluations",
            "ref_spans": []
        },
        {
            "text": "When faced with mitochondria damage, cells are known to switch to glycolysis to generate ATP; therefore the glucose\u2013galactose CC50 assay has been widely used to detect mitochondria toxicity.43 In the absence of glucose, the galactose-adapted cells are forced to rely heavily on mitochondrial OXPHOS and thus would show a \u22653-fold decrease in CC50.44 However, the predictivity of this assay was challenged by Hyne\u2019s 2013 report showing that this assay only detected 2\u20135% of the 200 potential mitochondrial toxins tested.44,45 Even though no nucleoside/tide analogs were included in Hyne\u2019s study, it is consistent with our finding from testing >30 clinically relevant nucleoside/tide analogs. None of the known mitochondrial toxins such as ddC, FIAU, or 4\u2032-azido C showed enhanced cytotoxicity in galactose-adapted cells.",
            "cite_spans": [
                {
                    "start": 190,
                    "end": 192,
                    "mention": "43",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 346,
                    "end": 348,
                    "mention": "44",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 518,
                    "end": 520,
                    "mention": "44",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 521,
                    "end": 523,
                    "mention": "45",
                    "ref_id": "BIBREF39"
                }
            ],
            "section": "An assay with limited predictive value: The glucose\u2013galactose CC50 assay ::: Cellular evaluations",
            "ref_spans": []
        },
        {
            "text": "Research and development of a significant number of nucleoside/tide analogs were terminated in the pre-clinical stage due to toxicity in the animal models; though only a few were reported24,46,47 and mitochondrial toxicity was indicated or suspected. To date, due to a number of factors outlined above, mitochondrial toxicity has been difficult to detect in animal species and correlation to humans is at best tenuous.48 Potentially, animal models with genetic mitochondrial abnormalities or humanized animals may be more sensitive to nucleoside/tide toxicity. For example, mice models with genetic mitochondrial abnormalities such as heterozygous superoxide dismutase 2 knockout (Sod+/\u2212) mice were more susceptible to mitochondria toxins than the wild-type animals.49 Recently, Xu et al. reported FIAU-induced liver toxicity in chimeric TK-NOG mice grafted with humanized livers.50 Animal models like these may improve our ability to detect nucleoside toxicity.",
            "cite_spans": [
                {
                    "start": 187,
                    "end": 189,
                    "mention": "24",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 190,
                    "end": 192,
                    "mention": "46",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 193,
                    "end": 195,
                    "mention": "47",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 418,
                    "end": 420,
                    "mention": "48",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 766,
                    "end": 768,
                    "mention": "49",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 880,
                    "end": 882,
                    "mention": "50",
                    "ref_id": "BIBREF45"
                }
            ],
            "section": "Evaluation of toxicity in animal studies",
            "ref_spans": []
        },
        {
            "text": "As viral diseases vary greatly in duration and severity, the safety threshold of an antiviral nucleoside/tide needs to be considered in the context of its efficacy and treatment duration. For example, compounds to treat acute and deadly viral infections such as Ebola would likely have different safety criteria than drugs used to control chronic infections such as HIV-1 and HBV. Existing nucleoside/tides are routinely screened against emerging viruses, and it is possible that a compound that failed to achieve an adequate therapeutic window against one virus may be suitable for treating other viral infections.",
            "cite_spans": [],
            "section": "A comment on therapeutic window",
            "ref_spans": []
        },
        {
            "text": "Anti-viral nucleoside/tide analogs target the viral DNA and RNA replication machinery, and this mechanism makes them potential inhibitors of host DNA and RNA synthesis as well, especially mitochondrial DNA and RNA synthesis. Mitochondrial toxicity manifests in multiple forms in vivo and underlies many clinical-stage failures and has been difficult to detect in animal studies. Over the past 30 years, a battery of in vitro tests for mitochondrial toxicity has evolved and continues to expand, allowing for improved early detection of mitochondrial liability. As for any drug molecule, the actual toxicity liability cannot be assessed fully until tested in animal toxicity studies and eventually in human clinical trials. Nevertheless, we believe that employing the proper biochemical and cellular assays early on will have a meaningful impact on reducing pre-clinical and clinical toxicity liability for this class of compounds.",
            "cite_spans": [],
            "section": "Summary",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1.: Biochemical and cellular assays to evaluate general and mitochondria toxicities of nucleoside/tide analogs.\n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Figure 1.: Chemical structures of compounds discussed in this review.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Nobel lecture: The purine path to chemotherapy",
            "authors": [
                {
                    "first": "GB.",
                    "middle": [],
                    "last": "Elion",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Ultrastructural changes associated with reduced mitochondrial DNA and impaired mitochondrial function in the presence of 2'3'-dideoxycytidine",
            "authors": [
                {
                    "first": "LD",
                    "middle": [],
                    "last": "Lewis",
                    "suffix": ""
                },
                {
                    "first": "FM",
                    "middle": [],
                    "last": "Hamzeh",
                    "suffix": ""
                },
                {
                    "first": "PS.",
                    "middle": [],
                    "last": "Lietman",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "Antimicrob Agents Chemother",
            "volume": "36",
            "issn": "",
            "pages": "2061-2065",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Arnaudo",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Dalakas",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Shanske",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "Lancet",
            "volume": "337",
            "issn": "",
            "pages": "508-510",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Human mitochondrial DNA polymerase holoenzyme: reconstitution and characterization",
            "authors": [
                {
                    "first": "AA",
                    "middle": [],
                    "last": "Johnson",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Tsai",
                    "suffix": ""
                },
                {
                    "first": "SW",
                    "middle": [],
                    "last": "Graves",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Biochemistry",
            "volume": "39",
            "issn": "",
            "pages": "1702-1708",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "",
            "authors": [],
            "year": 1995,
            "venue": "Review of the fialuridine (FIAU) clinical trials",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Depletion of mitochondrial DNA, destruction of mitochondria, and accumulation of lipid droplets result from fialuridine treatment in woodchucks (Marmota monax)",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Lewis",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Griniuviene",
                    "suffix": ""
                },
                {
                    "first": "KO",
                    "middle": [],
                    "last": "Tankersley",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Lab Invest",
            "volume": "76",
            "issn": "",
            "pages": "77-87",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Hepatic failure and lactic acidosis due to fialuridine (FIAU): An investigational nucleoside analogue for chronic hepatitis B",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "McKenzie",
                    "suffix": ""
                },
                {
                    "first": "MW",
                    "middle": [],
                    "last": "Fried",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Sallie",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "N Engl J Med",
            "volume": "333",
            "issn": "",
            "pages": "1099-1105",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "",
            "authors": [],
            "year": 2006,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nuleoside analogues",
            "authors": [
                {
                    "first": "NA.",
                    "middle": [],
                    "last": "Brown",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Expert Opin Investig Drugs",
            "volume": "18",
            "issn": "",
            "pages": "709-725",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "",
            "authors": [],
            "year": 2012,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "",
            "authors": [],
            "year": 2013,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "",
            "authors": [
                {
                    "first": "JY",
                    "middle": [],
                    "last": "Feng",
                    "suffix": ""
                },
                {
                    "first": "PA.",
                    "middle": [],
                    "last": "Furman",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nucleoside triphosphates and their analogs: Chemistry, biotechnology, and biological applications",
            "volume": "",
            "issn": "",
            "pages": "343-356",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Role of mitochondrial RNA polymerase in the toxicity of nucleotide inhibitors of hepatitis C virus",
            "authors": [
                {
                    "first": "JY",
                    "middle": [],
                    "last": "Feng",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Barauskas",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Antimicrob Agents Chemother",
            "volume": "60",
            "issn": "",
            "pages": "806-817",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Jin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kinkade",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Behera",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Antiviral Res",
            "volume": "143",
            "issn": "",
            "pages": "1-43",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides",
            "authors": [
                {
                    "first": "JJ",
                    "middle": [],
                    "last": "Arnold",
                    "suffix": ""
                },
                {
                    "first": "SD",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                },
                {
                    "first": "JY",
                    "middle": [],
                    "last": "Feng",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "PLoS Pathog",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Banerjee",
                    "suffix": ""
                },
                {
                    "first": "KR.",
                    "middle": [],
                    "last": "Reddy",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Aliment Pharmacol Ther",
            "volume": "43",
            "issn": "",
            "pages": "674-696",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Antiviral nucleotide incorporation by recombinant human mitochondrial RNA polymerase is predictive of increased in vivo mitochondrial toxicity risk",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Fenaux",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Yokokawa",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Antimicrob Agents Chemother",
            "volume": "60",
            "issn": "",
            "pages": "7077-7085",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Interferon-free strategies with a nucleoside/nucleotide analogue",
            "authors": [
                {
                    "first": "JJ.",
                    "middle": [],
                    "last": "Feld",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Semin Liver Dis",
            "volume": "34",
            "issn": "",
            "pages": "37-46",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "Book reviews: Letters to the editor",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bari",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Josephson",
                    "suffix": ""
                },
                {
                    "first": "AM",
                    "middle": [],
                    "last": "Prince",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "New Engl J Med",
            "volume": "334",
            "issn": "",
            "pages": "1135-1138",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "",
            "authors": [],
            "year": 2011,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "",
            "authors": [],
            "year": 2013,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "",
            "authors": [
                {
                    "first": "BR",
                    "middle": [],
                    "last": "Baumgart",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kwagh",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "Nucleoside analogues and nucleobases in cancer treatment",
            "authors": [
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Galmarini",
                    "suffix": ""
                },
                {
                    "first": "JR",
                    "middle": [],
                    "last": "Mackey",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Dumontet",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Lancet Oncol",
            "volume": "3",
            "issn": "",
            "pages": "415-424",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF23": {
            "title": "3'-Azido-3'-deoxythymidine (AZT) is a competitive inhibitor of thymidine phosphorylation in isolated rat heart and liver mitochondria",
            "authors": [
                {
                    "first": "MD",
                    "middle": [],
                    "last": "Lynx",
                    "suffix": ""
                },
                {
                    "first": "EE.",
                    "middle": [],
                    "last": "McKee",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Biochem Pharmacol",
            "volume": "72",
            "issn": "",
            "pages": "239-243",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "Mechanisms of action of ribavirin against distinct viruses",
            "authors": [
                {
                    "first": "JD",
                    "middle": [],
                    "last": "Graci",
                    "suffix": ""
                },
                {
                    "first": "CE.",
                    "middle": [],
                    "last": "Cameron",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Rev Med Virol",
            "volume": "16",
            "issn": "",
            "pages": "37-48",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrug",
            "authors": [
                {
                    "first": "JY",
                    "middle": [],
                    "last": "Feng",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Perry",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Antimicrob Agents Chemother",
            "volume": "58",
            "issn": "",
            "pages": "1930-1942",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Jin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kinkade",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Behera",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Antiviral Res",
            "volume": "143",
            "issn": "",
            "pages": "151-161",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "In vitro cell death determination for drug discovery: A landscape review of real issues",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Mery",
                    "suffix": ""
                },
                {
                    "first": "JB",
                    "middle": [],
                    "last": "Guy",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Vallard",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "J Cell Death",
            "volume": "10",
            "issn": "",
            "pages": "1-8",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Birkus",
                    "suffix": ""
                },
                {
                    "first": "MJM",
                    "middle": [],
                    "last": "Hitchcock",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Cihlar",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Antimicrob Agents Chemother",
            "volume": "46",
            "issn": "",
            "pages": "716-723",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "An evaluation of the toxicities of 2'-fluorouridine and 2'-fluorocytidine-HCl in F344 rats and woodchucks (Marmota monax)",
            "authors": [
                {
                    "first": "FC",
                    "middle": [],
                    "last": "Richardson",
                    "suffix": ""
                },
                {
                    "first": "BC",
                    "middle": [],
                    "last": "Tennant",
                    "suffix": ""
                },
                {
                    "first": "DJ",
                    "middle": [],
                    "last": "Meyer",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Toxicol Pathol",
            "volume": "27",
            "issn": "",
            "pages": "607-617",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "",
            "authors": [],
            "year": 2006,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF31": {
            "title": "Investigating drug-induced mitochondrial toxicity: a biosensor to increase drug safety?",
            "authors": [
                {
                    "first": "CV",
                    "middle": [],
                    "last": "Pereira",
                    "suffix": ""
                },
                {
                    "first": "AC",
                    "middle": [],
                    "last": "Moreira",
                    "suffix": ""
                },
                {
                    "first": "SP",
                    "middle": [],
                    "last": "Pereira",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Curr Drug Saf",
            "volume": "4",
            "issn": "",
            "pages": "34-54",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "The significance of mitochondrial toxicity testing in drug development",
            "authors": [
                {
                    "first": "JA",
                    "middle": [],
                    "last": "Dykens",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Will",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Drug Discov Today",
            "volume": "12",
            "issn": "",
            "pages": "777-785",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF33": {
            "title": "Inhibition of cellular \u03b1 and virally induced deoxyribonucleic acid polymerases by the triphosphate of acyclovir",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Clair",
                    "suffix": ""
                },
                {
                    "first": "MH",
                    "middle": [],
                    "last": "Furman",
                    "suffix": ""
                },
                {
                    "first": "PA",
                    "middle": [],
                    "last": "Lubbers",
                    "suffix": ""
                }
            ],
            "year": 1980,
            "venue": "Antimicrob Agents Chemother",
            "volume": "18",
            "issn": "",
            "pages": "741\u201374-5",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF34": {
            "title": "A high-throughput respirometric assay for mitochondrial biogenesis and toxicity",
            "authors": [
                {
                    "first": "CC",
                    "middle": [],
                    "last": "Beeson",
                    "suffix": ""
                },
                {
                    "first": "GC",
                    "middle": [],
                    "last": "Beeson",
                    "suffix": ""
                },
                {
                    "first": "RG.",
                    "middle": [],
                    "last": "Schnellmann",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Anal Biochem",
            "volume": "404",
            "issn": "",
            "pages": "75-81",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "Assessment of drug-induced mitochondrial dysfunction via altered cellular respiration and acidification measured in a 96-well platform",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nadanaciva",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Rana",
                    "suffix": ""
                },
                {
                    "first": "GC",
                    "middle": [],
                    "last": "Beeson",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Bioenerg Biomembr",
            "volume": "44",
            "issn": "",
            "pages": "421-437",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF36": {
            "title": "Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nadanaciva",
                    "suffix": ""
                },
                {
                    "first": "MD",
                    "middle": [],
                    "last": "Aleo",
                    "suffix": ""
                },
                {
                    "first": "CJ",
                    "middle": [],
                    "last": "Strock",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Toxicol Appl Pharmacol",
            "volume": "272",
            "issn": "",
            "pages": "272-280",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF37": {
            "title": "Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants",
            "authors": [
                {
                    "first": "LD",
                    "middle": [],
                    "last": "Marroquin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hynes",
                    "suffix": ""
                },
                {
                    "first": "JA",
                    "middle": [],
                    "last": "Dykens",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Toxicol Sci",
            "volume": "97",
            "issn": "",
            "pages": "539-547",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF38": {
            "title": "A high-throughput dual parameter assay for assessing drug-induced mitochondrial dysfunction provides additional predictivity over two established mitochondrial toxicity assays",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hynes",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nadanaciva",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Swiss",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Toxicol In Vitro",
            "volume": "27",
            "issn": "",
            "pages": "560-569",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF39": {
            "title": "Mitochondrial toxicity assessment in industry - A decade of technology development and insight",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Will",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Dykens",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Expert Opin Drug Metab Toxicol",
            "volume": "10",
            "issn": "",
            "pages": "1061-1067",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF40": {
            "title": "",
            "authors": [],
            "year": 2012,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF41": {
            "title": "An adenosine nucleoside inhibitor of dengue virus",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Yin",
                    "suffix": ""
                },
                {
                    "first": "YL",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Schul",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Proc Natl Acad Sci USA",
            "volume": "106",
            "issn": "",
            "pages": "20435-20439",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF42": {
            "title": "Toxicology strategies for drug discovery: Present and future",
            "authors": [
                {
                    "first": "EA",
                    "middle": [],
                    "last": "Blomme",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Will",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Chem Res Toxicol",
            "volume": "29",
            "issn": "",
            "pages": "1-118",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF43": {
            "title": "Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities",
            "authors": [
                {
                    "first": "MM",
                    "middle": [],
                    "last": "Ong",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Latchoumycandane",
                    "suffix": ""
                },
                {
                    "first": "UA.",
                    "middle": [],
                    "last": "Boelsterli",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Toxicol Sci",
            "volume": "97",
            "issn": "",
            "pages": "205-213",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF44": {
            "title": "A 40-year journey in search of selective antiviral chemotherapy",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Annu Rev Pharmacol Toxicol",
            "volume": "51",
            "issn": "",
            "pages": "1-24",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF45": {
            "title": "Fialuridine induces acute liver failure in chimeric TK-NOG mice: A model for detecting hepatic drug toxicity prior to human testing",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Nishimura",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nishimura",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "PLoS Med",
            "volume": "11",
            "issn": "",
            "pages": "1-9",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF46": {
            "title": "Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy?",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Brinkman",
                    "suffix": ""
                },
                {
                    "first": "TN.",
                    "middle": [],
                    "last": "Kakuda",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Curr Opin Infect Dis",
            "volume": "13",
            "issn": "",
            "pages": "5-11",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF47": {
            "title": "Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase",
            "authors": [
                {
                    "first": "AA",
                    "middle": [],
                    "last": "Johnson",
                    "suffix": ""
                },
                {
                    "first": "AS",
                    "middle": [],
                    "last": "Ray",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hanes",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Biol Chem",
            "volume": "276",
            "issn": "",
            "pages": "40847-40857",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF48": {
            "title": "The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound, 2',3'-dideoxycytidine",
            "authors": [
                {
                    "first": "CH",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "YC.",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "J Biol Chem",
            "volume": "267",
            "issn": "",
            "pages": "2856-2859",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF49": {
            "title": "Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity",
            "authors": [
                {
                    "first": "CH",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Vazquez-Padua",
                    "suffix": ""
                },
                {
                    "first": "Y-C.",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "Mol Pharmacol",
            "volume": "39",
            "issn": "",
            "pages": "625-628",
            "other_ids": {
                "DOI": []
            }
        }
    }
}